Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Allogene Therapeutics
City of Hope Medical Center
Celgene
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Seattle Children's Hospital
Takara Bio Inc.
Bellicum Pharmaceuticals